Interstitial lung diseases: An observational study in patients admitted in "Marius Nasta" Institute of Pulmonology Bucharest, Romania, in 2011

Pneumologia

Volumn 62, Issue 4, 2013, Pages 206-211

  Strâmbu, Irina ^a   Belaconi, Ionela ^a   Stoicescu, Ileana ^a   Ioniţã, Diana ^b   Cojocaru, Felicia ^c   Niţã, Camelia ^c   Dospinoiu, Daniela ^c   Bumbãcea, Roxana ^b  

^a Marius Nasta Institute of Pulmonology Bucharest   (Romania)

^b Elias Emergency Hospital   (Romania)

^c ARENSIA Exploratory Medicine   (Romania)

Author keywords

Diagnosis; Idiopathic pulmonary fibrosis; Interstitial lung diseases; Undefined interstitial lung disease

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ALLERGIC PNEUMONITIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS PROTEINOSIS; LUNG SARCOIDOSIS; MIDDLE AGED; PATIENT CARE; RETROSPECTIVE STUDY; REVIEW; ROMANIA; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALVEOLITIS, EXTRINSIC ALLERGIC; CRYPTOGENIC ORGANIZING PNEUMONIA; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HOSPITALS, UNIVERSITY; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PATIENT CARE TEAM; PULMONARY ALVEOLAR PROTEINOSIS; RETROSPECTIVE STUDIES; ROMANIA; SARCOIDOSIS, PULMONARY; TREATMENT OUTCOME;

EID: 84891674468     PISSN: 20672993     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management.
2. Raghu G, Collard HR, Egan JJ, et al. on behalf of the ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med Vol 183. pp 788-824, 2011.
3. Strâmbu I, Ioni D, Belaconi I, Stoia I, Tudorache V. Romanian National Registry for Interstitial Lung Diseases and Sarcoidosis (REGIS): Rationale and methods. Pneumologia 2012, 61:20-24.
4. Thomeer MJ, Costabel U, Rizzato G, Poletti V, Demedts M. Comparison of registries of interstitial lung diseases in three European countries. Eur Resp J 2001; 18: Suppl.32, 114s-118s.
5. Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth L, King Jr TE, Wolters PJ, Collard HR. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Resp J September 1, 2013 vol. 42 no. 3 750-757.
6. Cottin V, Wells A. Unclassified or unclassifiable interstitial lung disease: Confusing or helpful disease category Eur Respir J. 2013 Sep; 42(3):576-9.
7. Roelandt M, Demedts M, Callebaut W et al. Epidemiology of interstitial lung disease (ILD) in Flanders: Registration by pneumologists in 1992- 1994. Working Group on ILD, VRGT. Acta Clin Belg. 1995; 50(5):260-8.
8. Schweisfurth H. Report by the Scientific Working Group for Therapy of Lung Diseases: German Fibrosis Register with initial results. Pneumologie. 1996 Dec; 50(12):899-901.
9. Schweisfurth H, Kieslich C, Satake N et al. How are interstitial lung diseases diagnosed in Germany Results of the scientific resgistry for the exploration of interstitial lung diseases ("Fibrosis registry") of the WATL. Pneumologie. 2003 Jul; 57(7):373-82.
10. Tinelli C, De Silvestri A, Richeldi L, Oggionni T. The Italian register for diffuse infiltrative lung disorders (RIPID): A four-year report. Sarcoidosis Vasc Diffuse Lung Dis 2005 Dec; 22 Suppl 1:S4-8.
11. Xaubet A, Ancochea J, Morell F et al.; Spanish Group on Interstitial Lung Diseases, SEPAR. Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis 2004 Mar; 21(1):64-70.
12. National Heart, Lung and Blood Institute. Commonly used threedrug regimen for idiopathic pulmonary fibrosis found harmful. http://www.nih.gov/news/ health/oct2011/nhlbi-21.htm Date last accessed: November, 7, 2013.
13. Wells AU, Behr J, Costabel U, Cottin V, Poletti V. Triple therapy in idiopathic pulmonary fibrosis: An alarming press release. Eur Resp J April 1, 2012 vol. 39 no. 4 805-806